GuidelineTransplantation and cellular therapy2022

Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Miguel-Angel Perales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.